197 related articles for article (PubMed ID: 24093514)
1. New insights into drug development for pediatric solid tumors: what preclinical data justify clinical trials in pediatric cancer?
Houghton PJ
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1135-8. PubMed ID: 24093514
[No Abstract] [Full Text] [Related]
2. Preclinical models for pediatric solid tumor drug discovery: current trends, challenges and the scopes for improvement.
Kumar S; Mokhtari RB; Yeger H; Baruchel S
Expert Opin Drug Discov; 2012 Nov; 7(11):1093-106. PubMed ID: 22998522
[TBL] [Abstract][Full Text] [Related]
3. International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer.
Vassal G; Houghton PJ; Pfister SM; Smith MA; Caron HN; Li XN; Shields DJ; Witt O; Molenaar JJ; Colombetti S; Schüler J; Stancato LF
Mol Cancer Ther; 2021 Aug; 20(8):1462-1468. PubMed ID: 34108262
[TBL] [Abstract][Full Text] [Related]
4. Microdialysis: an in vivo approach for measuring drug delivery in oncology.
Brunner M; Müller M
Eur J Clin Pharmacol; 2002 Jul; 58(4):227-34. PubMed ID: 12136367
[TBL] [Abstract][Full Text] [Related]
5. Developing new agents for the treatment of childhood cancer.
Kurmasheva R; Morton C; Houghton PJ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
[TBL] [Abstract][Full Text] [Related]
6. Harnessing preclinical mouse models to inform human clinical cancer trials.
Gutmann DH; Hunter-Schaedle K; Shannon KM
J Clin Invest; 2006 Apr; 116(4):847-52. PubMed ID: 16585951
[TBL] [Abstract][Full Text] [Related]
7. [Preclinical data as basis for the design of clinical studies].
Fichtner I
Onkologie; 2008; 31 Suppl 2():34-8. PubMed ID: 18487867
[TBL] [Abstract][Full Text] [Related]
8. An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.
Leighton JK; Saber H; Reaman G; Pazdur R
Regul Toxicol Pharmacol; 2016 Aug; 79():142-143. PubMed ID: 26952647
[No Abstract] [Full Text] [Related]
9. A critical appraisal of the "human tumor stem-cell assay".
Selby P; Buick RN; Tannock I
N Engl J Med; 1983 Jan; 308(3):129-34. PubMed ID: 6336820
[No Abstract] [Full Text] [Related]
10. Preclinical predictors of clinical safety: opportunities for improvement.
Sistare FD; DeGeorge JJ
Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
[TBL] [Abstract][Full Text] [Related]
11. Evaluating temsirolimus activity in multiple tumors: a review of clinical trials.
Dancey JE; Curiel R; Purvis J
Semin Oncol; 2009 Dec; 36 Suppl 3():S46-58. PubMed ID: 19963100
[TBL] [Abstract][Full Text] [Related]
12. Modeling human carcinomas: physiologically relevant 3D models to improve anti-cancer drug development.
Unger C; Kramer N; Walzl A; Scherzer M; Hengstschläger M; Dolznig H
Adv Drug Deliv Rev; 2014 Dec; 79-80():50-67. PubMed ID: 25453261
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials in drug development: a minimalistic approach.
Verweij J
Curr Opin Oncol; 2012 May; 24(3):332-7. PubMed ID: 22343389
[TBL] [Abstract][Full Text] [Related]
14. Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel.
Sémiond D; Sidhu SS; Bissery MC; Vrignaud P
Cancer Chemother Pharmacol; 2013 Sep; 72(3):515-28. PubMed ID: 23820961
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of tumor size response metrics to predict survival in oncology clinical trials.
Bruno R; Mercier F; Claret L
Clin Pharmacol Ther; 2014 Apr; 95(4):386-93. PubMed ID: 24419563
[TBL] [Abstract][Full Text] [Related]
16. Oncology trials gear up for high-throughput sequencing.
Mullard A
Nat Rev Drug Discov; 2012 Apr; 11(5):339-40. PubMed ID: 22543457
[No Abstract] [Full Text] [Related]
17. Human tumor cloning: drug sensitivity testing clinical correlations.
Alberts DS; Salmon SE; Moon TE
Prog Clin Cancer; 1982; 8():147-79. PubMed ID: 6760247
[No Abstract] [Full Text] [Related]
18. Improving the evaluation of new cancer treatments: challenges and opportunities.
Rothenberg ML; Carbone DP; Johnson DH
Nat Rev Cancer; 2003 Apr; 3(4):303-9. PubMed ID: 12671669
[TBL] [Abstract][Full Text] [Related]
19. Reanalysis of cancer drugs: old drugs, new tricks.
Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ
Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099
[No Abstract] [Full Text] [Related]
20. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
